Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 8/20 | 0.41 |
| ▸ | RARA | P10276 | 7/20 | 0.41 |
| ▸ | RARG | P13631 | 7/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6175740 | 0.89 | RARA (0.33) | RARBRARARARG | |
| SCHEMBL6176106 | 0.78 | — | — | |
| SCHEMBL6177623 | 0.78 | — | — | |
| SCHEMBL13450327 | 0.74 | RARB (0.43) | RARBRARARARG | |
| SCHEMBL6017295 | 0.74 | RARB (0.39) | RARBRARARARG | |
| SCHEMBL6175908 | 0.71 | RARB (0.44) | RARBRARARARG | |
| SCHEMBL6177290 | 0.70 | RARB (0.62) | RARBRARARARG | |
| SCHEMBL4431042 | 0.70 | RARB (0.55) | RARBRARARARG | |
| SCHEMBL7668584 | 0.69 | RARB (0.44) | RARBRARARARG | |
| SCHEMBL7674828 | 0.67 | RARB (0.54) | RARBRARARARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260000631-A1 | SYNTHETIC RETINOIDS FOR USE IN RAR ACTIVATION | UNIVERSITY OF DURHAM (GB) | 2026-01-01 | — | — | US | disclosed |
| US-12344587-B2 | Synthetic retinoids for use in RAR activation | UNIVERSITY OF DURHAM (GB) | 2025-07-01 | — | — | US | disclosed |
| EP-4414355-A2 | SYNTHETIC RETINOIDS FOR USE IN RAR ACTIVATION | University of Durham (GB) | 2024-08-14 | — | — | EP | disclosed |
| EP-3937923-B1 | SYNTHETIC RETINOIDS FOR USE IN RAR ACTIVATION | UNIV DURHAM (GB) | 2024-07-24 | — | — | EP | disclosed |
| US-20220144783-A1 | SYNTHETIC RETINOIDS FOR USE IN RAR ACTIVATION | UNIVERSITY OF DURHAM (GB) | 2022-05-12 | — | — | US | disclosed |
| EP-3937923-A2 | SYNTHETIC RETINOIDS FOR USE IN RAR ACTIVATION | University Of Durham (GB) | 2022-01-19 | — | — | EP | disclosed |
| CN-113677667-A | Synthetic retinoids for RAR activation | 杜伦大学 | 2021-11-19 | — | — | CN | disclosed |
| WO-2020183173-A2 | SYNTHETIC RETINOIDS FOR USE IN RAR ACTIVATION | UNIVERSITY OF DURHAM (GB) | 2020-09-17 | — | — | WO | disclosed |
| EP-1559709-A1 | Heterocycle-containing carboxylic acid derivative and drug containing the same | Eisai Co., Ltd. (JP) | 2005-08-03 | — | — | EP | disclosed |
| EP-0838453-B1 | HETEROCYCLIC CARBOXYLIC ACID DERIVATIVES AND DRUGS CONTAINING THE SAME | EISAI CO LTD (JP) | 2005-04-27 | — | — | EP | disclosed |
| US-6884808-B2 | Heterocycle-containing carboxylic acid derivative and drug containing the same | EISAI CO. LTD. (JP) | 2005-04-26 | — | — | US | disclosed |
| US-6630463-B2 | Such as 4-(4-(2-(2-(5,6,7,8-tetrahydro-5,5,8,8 -tetramethylquinoxalyl))pyrrolyl))benzoic acid; for treatment of acute promyelocytic leukemia | EISAI CO. LTD. (JP) | 2003-10-07 | — | — | US | disclosed |
| US-20030144276-A1 | Heterocycle-containing carboxylic acid derivative and drug containing the same | EISAI CO. LTD. | 2003-07-31 | — | — | US | disclosed |
| US-6541474-B2 | Administering a pharmaceutically effective dose of the heterocycle-containing carboxylic acid derivative or salt to a patient suffering form acute promyelocytic leukemia | EISAI CO. LTD. (JP) | 2003-04-01 | — | — | US | disclosed |
| US-20020103234-A1 | Heterocycl-containing carboxylic acid derivative and drug containing the same | EISAI CO. LTD. | 2002-08-01 | — | — | US | disclosed |
| US-20020032202-A1 | Heterocycle-containing carboxylic acid derivative and drug containing the same | EISAI CO. LTD. | 2002-03-14 | — | — | US | disclosed |
| US-6329402-B1 | FOR THERAPY OF ACUTE PROMYELOCYTIC LEUKEMIA | EISAI CO., LTD. (JP) | 2001-12-11 | — | — | US | disclosed |
| US-5977108-A | LEUKEMIA | EISAI CO., LTD (JP) | 1999-11-02 | — | — | US | disclosed |
| EP-0838453-A1 | HETEROCYCLIC CARBOXYLIC ACID DERIVATIVES AND DRUGS CONTAINING THE SAME | Eisai Co., Ltd. (JP) | 1998-04-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020103234-A1 | Heterocycl-containing carboxylic acid derivative and drug containing the same | RARA, RARB, RARG | RARB 2/4885RARA 1/4885RARG 3/4885 |
| US-20260000631-A1 | SYNTHETIC RETINOIDS FOR USE IN RAR ACTIVATION | RARB, RARA, RXRA | RARB 1/4885RARA 2/4885RARG 5/4885 |
| US-20030144276-A1 | Heterocycle-containing carboxylic acid derivative and drug containing the same | RARA, RARB, RARG | RARB 2/4885RARA 1/4885RARG 3/4885 |
| US-20220144783-A1 | SYNTHETIC RETINOIDS FOR USE IN RAR ACTIVATION | RARA, RXRA, RARB | RARB 3/4885RARA 1/4885RARG 4/4885 |
| US-12344587-B2 | Synthetic retinoids for use in RAR activation | RARA, RXRA, RARB | RARB 3/4885RARA 1/4885RARG 4/4885 |
| US-20020032202-A1 | Heterocycle-containing carboxylic acid derivative and drug containing the same | RARA, RARB, RARG | RARB 2/4885RARA 1/4885RARG 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.